Vertex Pharmaceuticals Incorporated /
Crinetics Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated completed its deal for Crinetics Pharmaceuticals, Inc.
Source for the buyer and target: Crinetics Pharmaceuticals, Inc.
For the buyer and target.
“Agreement and Plan of Merger by and among Crinetics Pharmaceuticals, Inc., Vertex Pharmaceuticals Incorporated and Clark Merger Sub, Inc., dated as of July 6, 2026, (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed with the SEC on July 6, 2026).”
Published 1 Sep 2026
Open the sourceWhat happened
The deal for Crinetics Pharmaceuticals, Inc. has closed, with Vertex Pharmaceuticals Incorporated as the buyer, at a stated price of approximately $10.0 billion. [01]
The filing from Crinetics Pharmaceuticals, Inc. is dated Sept. 1, 2026. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Vertex Pharmaceuticals Incorporated completed its deal for Crinetics Pharmaceuticals, Inc.
This document is the source for the companies, stage, figure and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly